EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of PET/CT in Breast Cancer

Bawinile Hadebe, Lerwine Harry, Tasmeera Ebrahim, Venesen Pillay, Mariza Vorster

Diagnostics · 06.02.2023 · 13 (4) · 597

DOI: 10.3390/diagnostics13040597 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 06.02.2023. Verfasst von Bawinile Hadebe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Private Bag X54001, Durban 4001, South Africa. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer worldwide, with an estimated 2.3 million new cases (11.7%), followed by lung cancer (11.4%) The current literature and the National Comprehensive Cancer Network (NCCN) guidelines state that 18F-FDG PET/CT is not routine for early diagnosis of breast cancer, and rather PET/CT scanning should be performed for patients with stage III disease or when conventional staging studies yield non-diagnostic or suspicious results because this modality has been shown to upstage patients compared to conventional imaging and thus has an impact on disease management and prognosis. Furthermore, with the growing interest in precision therapy in breast cancer, numerous novel radiopharmaceuticals have been developed that target tumor biology and have the potential to non-invasively guide the most appropriate targeted therapy. This review discusses the role of 18F-FDG PET and other PET tracers beyond FDG in breast cancer imaging.

Schlagwörter

Stichwörter der Autor:innen

PETbreast cancer

Autor:innen und Institutionen

  • Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Private Bag X54001, Durban 4001, South Africa.
  • Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.

Zitieren

APA

Hadebe, B., Harry, L., Ebrahim, T., Pillay, V., & Vorster, M. (2023). The Role of PET/CT in Breast Cancer. Diagnostics, 13(4), 597. https://doi.org/10.3390/diagnostics13040597

Vancouver

Hadebe B, Harry L, Ebrahim T, Pillay V, Vorster M. The Role of PET/CT in Breast Cancer. Diagnostics. 2023;13(4):597. doi:10.3390/diagnostics13040597

BibTeX
@article{Hadebe2023,
  author = {Hadebe, Bawinile and Harry, Lerwine and Ebrahim, Tasmeera and Pillay, Venesen and Vorster, Mariza},
  title = {The Role of PET/CT in Breast Cancer},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {597},
  doi = {10.3390/diagnostics13040597}
}
Kostenlos starten →